Recruitment and representativeness of blood donors in the INTERVAL randomised trial assessing varying inter-donation intervals

Trials

Volumn 17, Issue 1, 2016, Pages

  Moore, Carmel ^a   Bolton, Thomas ^a   Walker, Matthew ^a   Kaptoge, Stephen ^a   Allen, David ^b   Daynes, Michael ^c   Mehenny, Susan ^c   Sambrook, Jennifer ^c,d   Watkins, Nicholas A ^c   Miflin, Gail ^a,c   Di Angelantonio, Emanuele ^a   Ouwehand, Willem H ^c,d,e   Roberts, David J ^a,b,f   Danesh, John ^a   Thompson, Simon G ^a,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Blood donation; Blood donors; Generalisability; Randomised trial; Recruitment; Representativeness

Indexed keywords

HEMOGLOBIN;

ADULT; AGE; AGED; ARTICLE; BLOOD DONOR; BLOOD GROUP; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ENGLAND; ETHNICITY; FEMALE; GENDER; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTER DONATION INTERVAL; MALE; MIDDLE AGED; PARTICIPANT RECRUITMENT; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX RATIO; SOCIAL PARTICIPATION; YOUNG ADULT; ADOLESCENT; BLOOD BANK; COMPARATIVE STUDY; DONOR SELECTION; HEALTH STATUS; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; TIME FACTOR;

ADOLESCENT; ADULT; AGED; BLOOD BANKS; BLOOD DONORS; DONOR SELECTION; ENGLAND; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; TIME FACTORS; YOUNG ADULT;

EID: 84988470891     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-016-1579-7     Document Type: Article

References (8)

1. Moore C, Sambrook J, Walker M, Tolkien Z, Kaptoge S, Allen D, Mehenny S, Mant J, Di Angelantonio E, Thompson SG, et al. The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial. Trials. 2014;15:363.
2. NHS Blood and Transplant. Blood 2020. A strategy for the blood supply in England and North Wales. http://www.nhsbt.nhs.uk/download/blood-2020.pdf. Accessed 6 May 2016.
3. Williamson LM, Devine DV. Challenges in the management of the blood supply. Lancet. 2013;381(9880):1866-75.
4. Fendrich K, Hoffmann W. More than just aging societies: the demographic change has an impact on actual numbers of patients. J Public Health. 2007;15(5):345-51.
5. Bonig H, Schmidt M, Hourfar K, Schuttrumpf J, Seifried E. Sufficient blood, safe blood: can we have both? BMC Med. 2012;10:29.
6. Maruish ME. User's manual for the SF-36v2 Health Survey. 3rd ed. Lincoln, RI: QualityMetric Incorporated; 2011.
7. Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?". Lancet. 2005;365(9453):82-93.
8. Public Health England. Safe supplies: reflecting on the population. Annual Review from the NHS Blood and Transplant/Public Health England Epidemiology Unit. 2013. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/448050/NHSBT_PHE_Epidemiology_Unit_Annual_Review_2013_FINAL_-_Revised.pdf. Accessed 6 May 2016.